615 related articles for article (PubMed ID: 6287385)
1. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
[TBL] [Abstract][Full Text] [Related]
2. [In vitro bacteriostatic activity of cefmenoxime (SCE 1365), cefotaxime and moxalactam].
Husson MO; Bryskier A; Izard D; Leclerc H
Pathol Biol (Paris); 1983 May; 31(5):347-50. PubMed ID: 6312395
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of ceftazidime and ceftriaxone.
Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL
Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195
[TBL] [Abstract][Full Text] [Related]
4. [Moxalactam and cefotaxime--two new beta-lactam antibiotics compared with three well-known cephalosporins].
Baumgärtner M; Dickgiesser N; Müller S; Wundt W
Arzneimittelforschung; 1981; 31(10):1677-81. PubMed ID: 6274361
[TBL] [Abstract][Full Text] [Related]
5. [In vitro antibacterial activity of eight third generation cephalosporins (author's transl)].
Deforges L; Le Van Thoi J; Soussy CJ; Duval J
Pathol Biol (Paris); 1982 Jun; 30(6):363-9. PubMed ID: 6810282
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon].
Baumgärtner M; Grehn M; Wundt W
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):208-21. PubMed ID: 6289564
[TBL] [Abstract][Full Text] [Related]
7. [In vitro activity of cefmenoxime (SCE 1365) against 616 hospital strains of gram-negative bacilli chosen for beta-lactam resistance. Comparison with cefotaxime, lamoxactam and ceftazidime].
Le Noc P; Bryskier A; Le Noc D
Pathol Biol (Paris); 1983 May; 31(5):351-6. PubMed ID: 6312396
[TBL] [Abstract][Full Text] [Related]
8. [In vitro activity of ceftriaxone on hospital bacteria. Results of a multicenter study].
Soussy CJ; Deforges L; Le Van Thoi J; Chanal M; Sirot D; Acar JF; Kitzis MD; Thabaut A; Meyran M; Dabernat H
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):469-72. PubMed ID: 2868442
[TBL] [Abstract][Full Text] [Related]
9. [Cefotaxime, moxalactam and ceftriaxone: comparison of in vitro activity against hospital strains of Enterobacteriaceae belonging to the 4 principal phenotypes of sensitivity to beta-lactams].
Jarlier V; Bismuth R; Grosset J
Pathol Biol (Paris); 1983 May; 31(5):336-42. PubMed ID: 6312393
[TBL] [Abstract][Full Text] [Related]
10. [In-vitro activity of ceftriaxone on Gram-negative bacilli with various resistance phenotypes to cephalosporins. Comparison with cefotaxime, cefmenoxime, moxalactam, ceftazidime].
Rouhan D; Le Noc P; Le Noc D
Pathol Biol (Paris); 1986 May; 34(5):404-9. PubMed ID: 3534713
[TBL] [Abstract][Full Text] [Related]
11. [In vitro action of moxalactam on hospital bacteria. Results of a multicenter survey].
Duval J; Deforges L; Bergogne-Berezin E; Chabbert YA; Courtieu AL; Cluzel R; Dabernat H; Witchitz JL
Sem Hop; 1983 Jun; 59(26):1949-52. PubMed ID: 6310784
[TBL] [Abstract][Full Text] [Related]
12. [In vitro activity of cefotaxime, latamoxef and ceftriaxone on hospital strains of Enterobacteriaceae resistant to cefalotine and cefoxitine].
Berche P; Gaillard JL
Ann Biol Clin (Paris); 1986; 44(6):624-7. PubMed ID: 3826779
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial activity of moxalactam (LY-127935) compared with cefotaxime and other beta-lactam antibiotics against clinical isolates of enterobacteriacea and non-fermenters.
Verbist L
Arzneimittelforschung; 1981; 31(6):982-6. PubMed ID: 6266430
[TBL] [Abstract][Full Text] [Related]
14. [Statistical regression analysis for four new cephalosporins (author's transl)].
Sirot D; Glanddier Y; Chanal M; Sirot J; Cluzel R
Pathol Biol (Paris); 1982 Jun; 30(6):357-62. PubMed ID: 6287389
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro activities of third-generation cephalosporins.
Fass RJ
Arch Intern Med; 1983 Sep; 143(9):1743-5. PubMed ID: 6615095
[TBL] [Abstract][Full Text] [Related]
16. [Comparative activity of dibekacin and several cephalosporins on Pseudomonas aeruginosa].
Carlone NA; Cuffini AM; Forno-Pizzoglio M; Aragno M
G Batteriol Virol Immunol; 1983; 76(7-12):246-56. PubMed ID: 6099297
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of N-formimidoyl-thienamycin in comparison to that of moxalactam and cefotaxime against gentamicin-resistant gram-negative bacteria.
Pusztai-Markos Z; Pranada F
Eur J Clin Microbiol; 1982 Feb; 1(1):49-51. PubMed ID: 6293811
[TBL] [Abstract][Full Text] [Related]
18. [In vitro activity of cefatiolene (RP 42,980) against hospital bacteria. Comparison with cefotaxime and lamoxactam. Results of a multicenter study].
Duval J; Soussy CJ; Deforges L; Le Van Thoi J; Acar JF; Kitzis D; Dabernat H; Christol D; Bure A; Courtieu AL
Pathol Biol (Paris); 1983 May; 31(5):357-61. PubMed ID: 6312397
[TBL] [Abstract][Full Text] [Related]
19. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains].
Mascellino MT; Prignano G; Iegri F; Lorenzi A
Boll Ist Sieroter Milan; 1982; 61(4):309-19. PubMed ID: 6100234
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial activity of ceftriaxone: a review.
Cleeland R; Squires E
Am J Med; 1984 Oct; 77(4C):3-11. PubMed ID: 6093515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
